PAK1 and melanoma: P29S in Rac1 was initially identified as one of the major somatic mutations in human melanoma, shown to enhance Rac1 binding to various effector proteins, including PAK1 (p21 protein activated kinase 1), MLK3 (mixed-lineage kinase 3), and the WRC14,22,23.